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Abstract
Alteration and/or mutations of the ribonucleoprotein TDP-43 have been firmly linked to human neurodegenerative
diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The relative impacts
of TDP-43 alteration, mutation, or inherent protein function on neural integrity, however, remain less clear—a situation
confounded by conflicting reports based on transient and/or random-insertion transgenic expression. We therefore
performed a stringent comparative investigation of impacts of these TDP-43 modifications on neural integrity in vivo.T o
achieve this, we systematically screened ALS/FTLD-associated and synthetic TDP-43 isoforms via same-site gene insertion
and neural expression in Drosophila; followed by transposon-based motor neuron-specific transgenesis in a chick vertebrate
system. Using this bi-systemic approach we uncovered a requirement of inherent TDP-43 RNA-binding function—but not
ALS/FTLD-linked mutation, mislocalization, or truncation—for TDP-43-mediated neurotoxicity in vivo.
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Introduction
TAR-DNA binding protein-43 (TDP-43) is a multifunctional
heterogeneous ribonucleoprotein implicated in mRNA processing
and stabilization [1]. TDP-43 comprises two RNA recognition
motifs (RRMs), a nuclear localization signal and a nuclear export
sequence mediating nuclear shuttling, as well as a C-terminal
glycine-rich domain (GRD) implicated in TDP-43 protein
interactions and functions [1]. Cytosolic accumulation of truncat-
ed TDP-43 is found in affected neurons of patients suffering from
sporadic and familial ALS and FTLD [2,3]. Moreover, missense
mutations clustering in the TDP-43 GRD have been identified in
many cases of ALS (and FTLD) [1,4,5]. The precise impacts of the
missense mutations and/or aggregation of mutant, or wild type
TDP-43 for neuropathology, however, remain unclear. Based on a
number of recent in vitro and in vivo studies, both neurotoxic gain-
of-function and loss-of-function mechanisms have been proposed
linking TDP-43 proteinopathy to neuropathology [6,7]. For
instance, TDP-43 missense mutations have been suggested to
mildly increase truncation and cytosolic localization/aggregation
of the protein, and this has been correlated with increased
cytotoxicity [8,9]. The relationship between inherent protein
function, ALS/FTLD-linked missense mutations (TDP-43
MS), or
truncation/mislocalization and TDP-43-mediated neuropathology
in vivo, however, is less clear. This is further confounded by recent
studies separately reporting that either overexpression of wild type
TDP-43 (TDP-43
WT), or ALS/FTLD-linked TDP-43
MS,o r
inactivating endogenous TDP-43 [10,11,12,13,14] all lead to
neuron loss in vivo in different invertebrate and vertebrate models
[10,11,12,13,15,16]. In transgenic mice, for instance, forced
expression of TDP-43
WT and human ALS/FTLD-linked TDP-
43 variant TDP-43
A315T phenocopied pathological hallmarks of
TDP-43-linked ALS [12]. Recently, mutations in another
ribonucleoprotein FUS have been identified in ALS cases [17]
suggesting possible commonalities in mechanisms of these two
RNA-binding proteins that link TDP-43 and FUS to neurode-
generation [1,7]. This further raises the question to what extent
the inherent physiological activities exerted by TDP-43 contribute
to the toxic properties observed upon TDP-43 overexpression in
the different model systems. At this stage, a priority in the field
should therefore be the clarification of the relative impacts of
inherent TDP-43 protein function and ALS/FTLD-linked muta-
tion/alteration on neurotoxicity mediated by TDP-43 expression
in vivo.
Results
Stringent comparative assessment of TDP-43 mutation
and alteration via same-site controlled expression
We reasoned that a first step to clarify the role of TDP-43 in
ALS and FTLD would require a systematic and direct
comparative investigation of respective disease-linked variants of
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12247TDP-43 [4] on neural integrity in vivo—to alleviate seemingly
conflicting conclusions drawn from separate experiments address-
ing different TDP-43 variants in diverse systems at varying
expression levels. To achieve this, we generated expression
constructs for a series of TDP-43 variants, including TDP-43
WT,
synthetic mutants (TDP-43
SM) and ALS/FTLD-linked TDP-43
MS
(Fig. 1A). To analyze possible effects of TDP-43 mislocalization,
we introduced a synthetic protein modeled after the major TDP-
43 C-terminal fragment (TDP-43
CTF) found in cytosolic aggre-
gates of ALS/FTLD patients [3], as well as intra-cellularly
mislocalized full-length TDP-43 lacking a functional nuclear
localization signal (TDP-43
DNLS). TDP-43 is known to effectively
bind RNA [18,19] and this has been shown to result in
stabilization of bound mRNAs [20]. To investigate, whether this
intrinsic function of TDP-43 might be crucial for TDP-43-
mediated neurotoxic action, we introduced two missense muta-
tions (F147L/F149L) into the first RNA recognition motif (RRM1)
to abolish inherent TDP-43 RNA-binding function [21]. In
contrast to TDP-43
WT, TDP-43
FFLL displayed a complete loss to
bind to UG12 RNA oligomers in pull-down assays (Fig. 1B).
To comparatively analyze the effect of neural expression of the
respective human TDP-43 variants in vivo, we generated
transgenes utilizing w-C31 site-specific recombination in Drosophila
[22,23]. Expression of the transgenic constructs is controlled by
the UAS/Gal4 system, allowing targeted expression of TDP-43 in
a spatiotemporal manner [24]. To avoid possible interference of
protein-tag fusions with TDP-43 activity, we utilized ‘untagged’
proteins and verified their expression and relative protein levels
(Fig. 1C). Although we cannot entirely rule out the possibility that
the introduced mutations to some extent alter protein turnover/
stability, we were not able to detect obvious differences in the
expression levels of the different TDP-43 variants by Western blot
analysis. TDP-43
CTF lacks large portions of the epitope/s
detected by the available anti-TDP-43 antibody which results
in no/weak recognition of TDP-43
CTF compared to full length
protein in Western blot analysis [25]. For this reason, we assessed
relative TDP-43
CTF expression by quantitative RT-PCR (qRT-
PCR) analysis (Fig. 1D). First we analyzed transcript abundance
of both human TDP-43 and endogenous TBPH (fly homolog of
TDP-43) by qRT-PCR (Fig. 1D). The relative abundance of
TBPH transcripts was not significantly altered between non-
transgenic (OreR), transgenic (elav
C155::Gal4) controls and TDP-
43
WT expressing flies, indicating that TDP-43 expression had no
detectable impact on endogenous TBPH transcript levels in these
flies. Next we performed qRT-PCR of all TDP-43 variants
normalized to endogenous actin5C and TBPH. This analysis
revealed significantly higher transcript levels for TDP-43
CTF.
Although TDP-43
A315T and TDP-43
N390D expression levels were
found to be slightly, but significant elevated compared to that of
TDP-43
WT, the overall expression levels of TDP-43
MS variants
were similar (Fig. 1D).
Subcellular localization of TDP-43 variants in vitro and
in vivo
We next tested the subcellular localization of the different TDP-
43 variants in human embryonic kidney (HEK) cells (Fig. 2), non-
neuronal Drosophila cells (Fig. S1), as well as in neuronal Drosophila
cells and chick motor neurons (Fig. 3). The different TDP-43
variants tested displayed consistent subcellular localization pat-
terns in these different cell types (Fig. 2; Fig. 3; Fig. S1). In all
systems tested, ectopic TDP-43
WT mainly localized to the nucleus
(Fig. 2B; Fig. 3A; Fig. S1A), while TDP-43
DNLS displayed
predominant cytosolic localization (Fig. 2C, 3B, S1B), thus
demonstrating efficient disruption of the nuclear localization
Figure 1. Analysis of different TDP-43 variants used for ectopic
expression. (A) Schematic overview of TDP-43 variants tested in vivo.
Positions and nature of amino acid substitutions and size of two C-
terminal fragments (CTFs) analyzed are indicated. Synthetic mutations
(SM) were introduced to interfere with TDP-43 localization or function.
Mutations in the nuclear localization signal (DNLS) were introduced to
target TDP-43 to the cytoplasm and mutations F147L/F149L (FFLL) in
the first RNA recognition motive (RRM1) were introduced to impair TDP-
43 inherent RNA-binding capacity. (B) Loss of RNA-binding by TDP-
43
FFLL. Biotinylated oligonucleotides were incubated with lysates from
either untransfected HEK293 cells or HEK293 cells transfected with
FLAG-tagged TDP-43
WT or TDP-43
FFLL (left, input) followed by UV
crosslinking and streptavidin-pulldown of Biotin-RNA (right, pulldown).
Precipitates were separated, blotted and membranes probed with
FLAG- (upper panel) and TDP-43-specific (lower panel) antibodies to
assay co-precipitation of TDP-43. Note: Co-precipitation of endogenous
TDP-43 with (UG)12-repeats in all lysates. Ectopic FLAG-TDP-43
WT, but
not FLAG-TDP-43
FFLL co-precipitated with cognate UG repeats. GAPDH
served as loading control for protein input. (C) Equalized pan-neural
expression of w-C31-inserted TDP-43 variants in adult Drosophilae. TDP-
43 expression was visualized using an anti-human TDP-43 antibody.
Syntaxin served as loading control. (D) Assessment of relative TBPH and
TDP-43 expression levels. Left graph: Relative abundance of endoge-
nous TBPH transcripts in relation to actin5C of wild type strain OregonR
(OreR), the Gal4-driver line (elav
C155::Gal4) and flies with pan-neural TDP-
43 expression (elav
C155::Gal4/Y;UAS::TDP-43
WT/+). TBPH levels were not
significantly different in analyzed genotypes. Right graph: mRNA
abundance of TDP-43 in flies with pan-neural expression of the
different TDP-43 variants normalized to actin5C and TBPH mRNA levels.
Significant differences are indicated. *p,0.05; ***p,0.001. Head lysates
of flies with pan-neural expression of TDP-43 were used for Western
blot and qPCR analysis. elav::Gal4 flies without a TDP-43 transgene
(elav) were used as negative control.
doi:10.1371/journal.pone.0012247.g001
TDP-43 Neuron Loss
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variant, RNA-binding-deficient TDP-43
FFLL, predominantly lo-
calized to the nucleus and displayed a speckle-like pattern
consistent with previous reports [26] (Fig. 2D; Fig. 3C; Fig.
S1C). Similar to TDP-43
WT, TDP-43
A315T (Fig. 2F; Fig. 3D; Fig.
S1E), and all other TDP-43
MS tested mainly localized to the
nucleus (Fig. 2E–I; Fig. S1D–H). TDP-43
CTF which lacks the
NLS, displayed markedly cytoplasmic localization in HEK cells
and chick motor neurons, with occasional localization to
extranuclear foci (Fig. 2J; Fig. S3A). Similarly, GFP-tagged
TDP-43
CTF displayed cytoplasmic localization in Drosophila
neurons in vivo (Fig. S2C).
Pan-neural expression of TDP-43 reduces longevity in
Drosophila
We next analyzed the effect of ubiquitous and pan-neural
expression of all TDP-43 variants on viability (Table 1). With the
exception of TDP-43
CTF and TDP-43
FFLL, ubiquitous expression
of all TDP-43 variants tested resulted in premature lethality
(Table 1). Similarly, pan-neural expression of most TDP-43
variants resulted in shortened life-span compared to control
animals (Fig. 4A). However, comparison among TDP-43 express-
ing flies revealed profound variant-specific differences in relative
impacts on longevity (Fig. 4A). TDP-43
WT expressing flies
consistently displayed the most drastic reduction in life-span,
while TDP-43
CTF and TDP-43
FFLL displayed comparatively mild
reduction on longevity. Moreover, relative impacts on survival
differed among the TDP-43
MS expressing flies: TDP-43
N390D
displaying the lowest, TDP-43
A315T the highest reduction in
median survival (Fig. 4B). A detailed statistical cross-correlation
analysis revealed highly significant differences between the impacts
of both, TDP-43
WT and TDP-43
CTF to all TDP-43 variants on
longevity (Fig. 4C). In contrast, longevity curves of flies expressing
other TDP-43 variants displayed less significant, or no significant
differences to at least one other curve in the cross-correlation after
Bonferroni correction (Fig. 4C).
Figure 2. Localization of TDP-43 variants in human cells. HEK293E cells transfected with N-terminal Flag-tagged TDP-43 variants detected
with Flag- (left, green) and TDP-43 (middle, red) specific antibodies. Overlay (right) with Hoechst stained DNA (blue). (A) Exogenous TDP-43 had to be
visualized via fused Flag-tag, as HEK cells show robust endogenous expression of TDP-43. (B) Ectopic TDP-43
WT mainly localized to the nucleus. (C) In
contrast, TDP-43
DNLS exclusively localized to cytosol without showing nuclear Flag-signal. Similar to TDP-43
FFLL (D), also TDP-43
MS (E–I) displayed a
nuclear localization. However, TDP-43
FFLL localized in a characteristic punctuate pattern throughout the nucleus (D). (J) TDP-43
CTF displayed a
predominantly cytoplasmic localization similar to TDP-43
DNLS (compare C and J). Scale bar indicates 10 mm.
doi:10.1371/journal.pone.0012247.g002
TDP-43 Neuron Loss
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locomotion
We observed that TDP-43-induced lethality was preceded by
progressive impairment of locomotor activity and wing posture
(Video S1). To further investigate this, we utilized D42::Gal4-
mediated motor neuron-specific expression, followed by quantita-
tive assessment of motor performance through climbing assays
(Fig. 4D,E). At day one of the analysis, roughly 80–90% of tested
flies managed the climbing task. The slight reduction in climbing
ability of control flies (D42) compared to TDP-43 expressing flies
at day one of the analysis was unexpected. However, climbing
ability of control flies remained stable at day 10 and showed only a
slight reduction after 20 days. In contrast, expression of TDP-
43
WT and TDP-43
A315T led to significant progressive loss of motor
performance, with TDP-43
WT showing the highest reduction
(Fig. 4D,E), in line with the observed relative impacts of these
Figure 3. Localization of TDP-43 in Drosophila melanogaster and Gallus gallus. Confocal sections of eye imaginal discs from Drosophila larvae
(left panel) and motor neurons from Gallus (right panel) expressing indicated TDP-43 variants. To be able to discriminate between the two in vivo
systems, ectopic TDP-43 in Drosophila is shown in green, whereas TDP-43 in Gallus is shown in red. Subcellular localization of the different TDP-43
variants was found to be identical between fly and chick. TDP-43
WT (A) localized mainly to the nucleus, while TDP-43
DNLS (B) was found
predominantly in the cytoplasm. TDP-43
FFLL (C) and TDP-43
A315T (D) displayed a nuclear distribution. Only cells with very high expression levels of
usually nuclear TDP-43 displayed a detectable cytoplasmic staining (example in case of TDP-43
FFLL marked by asterisk). DNA was stained with SytoxH
Orange (fly, red) or DAPI (chick, white). Scale bar indicates 50 mm. Neuronal expression was mediated by elav::Gal4 (flies) or Hb9::Cre (chick).
doi:10.1371/journal.pone.0012247.g003
TDP-43 Neuron Loss
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TDP-43
WT expressing flies appeared paralytic, hardly showed
coordinated movement and failed to climb. Similar to control flies,
TDP-43
CTF and TDP-43
FFLL expressing flies showed a slight
reduction in locomotion over time (Fig. 4D), which most likely
reflects normal aging rather than detrimental effects of TDP-43 as
seen in TDP-43
WT and TDP-43
A315T expressing flies. Together,
these results thus reveal a requirement of TDP-43 RNA-binding
activity for TDP-43 mediated toxicity in vivo. Expression of both
variants, TDP-43
FFLL and TDP-43
CTF, lacking the first RRM
resulted in much weaker detrimental effects on longevity and
locomotion than TDP-43 variants with intact RRM1. At present,
however, we cannot strictly exclude that TDP-43
FFLL may retain
residual RNA/DNA binding activity exerted by the remaining first
RRM, which may underlay the slightly higher toxicity of TDP-
43
FFLL compared to TDP-43
CTF.
Dose-dependency of TDP-43-mediated neurotoxicity
In addition to our analysis of the same-site TDP-43 transgenes,
we further generated transgenes expressing GFP-tagged TDP-43
variants (TDP-43
WT:GFP, TDP-43
DNLS:GFP and TDP-
43
CTF:GFP) through random insertion transgenesis. In flies
expressing these variants, the intracellular localization of TDP-
43 mirrored that observed for the corresponding untagged TDP-
43 variants (Fig. S2). Since these lines displayed great differences in
expression levels, they allowed us to investigate possible dose-
dependency of TDP-43-mediated effects upon pan-neural and
ubiquitous expression (Table 2). Comparison of two TDP-
43
WT:GFP lines with different expression levels showed a
correlation between expression strength and longevity, with higher
expression levels inducing an earlier lethality upon pan-neural
expression (Fig. S4A). This indicated that TDP-43-mediated
effects were dose-dependent, which was further suggested by the
observation that two copies of UAS::TDP-43
WT-transgenes caused
lethality after pan-neural expression, whereas one copy did not
(not shown). Moreover, we identified one TDP-43
WT:GFP line to
cause lethality after pan-neural expression. However, this line
(TDP-43
WT:GFP#14) did not display a lethal phenotype after
muscle or glia-specific expression (Table 2), suggesting that effects
after pan-neural expression of TDP-43 were cell-intrinsic.
Next, we compared the impact of ubiquitous (DaG32::Gal4)
expression of TDP-43
WT:GFP, TDP-43
DNLS:GFP and TDP-
43
CTF:GFP on adult viability (Table 2). Almost no adult offspring
was obtained after ubiquitous expression of TDP-43
WT:GFP (10/11
independentlines)andTDP-43
DNLS:GFP(15/16independentlines).
Ubiquitous expression of TDP-43
CTF:GFP however, was never
observed to cause lethality (0/11 independent lines). Even lines with
markedly higher TDP-43
CTF:GFP expression levels than TDP-
43
WT:GFP did not result in a comparable decline in adult viability,
suggesting that TDP-43
CTF:GFP, similar to untagged TDP-43
CTF,
doesnotexertrobusttoxicity(Table2,Fig.S4A).Thus,the relatively
mild reduction in longevity and climbing in previous experiments
was most likely not related to TDP-43
CTF protein levels but rather
appeared to reflect low toxicity mediated by TDP-43
CTF per se.
To exclude that the observed reduction in longevity was due to
a developmental phenotype, we next used an adult-onset
expression system, utilizing a temperature sensitive inhibitor of
Gal4, Gal80
ts. Under restrictive conditions, transgene expression
was effectively silenced, but switched on within hours after shifting
flies to permissive conditions, and induced TDP-43 expression was
maintained for days (Fig. S4B). Intriguingly, pan-neural expression
of untagged TDP-43
WT in this assay also caused a strong
reduction in longevity, as compared to other TDP-43 variants
(Fig. S4C). These data indicate that TDP-43-induced reduction in
longevity was not dependent on developmental alterations of the
nervous system.
TDP-43-mediated motor neuron loss in chick mirrors
relative impacts of TDP-43 mutation/mislocalization in
Drosophila
We next investigated whether the relative activities of TDP-43
variants found in Drosophila would also manifest themselves in a
vertebrate system. We focused on the chick as a model, taking
advantage of the temporally compressed neuromuscular maturation
typical for precocial species. This model system thus facilitates ready
experimental access to mature vertebrate motor neurons through in
ovo transfection. To investigate impacts of TDP-43 expression in
chick motor neurons we employed a novel expression system
achieving stable neuron subtype-specific transgene expression in
chick in vivo (DM, DH, TM, unpublished). This was based on tol2-
transposon-mediated stable genomic insertion [27], combined with
restricted transgene-activation via postmitotic motor neuron-
specific Cre-recombination mediated by an Hb9::Cre driver
construct. This system facilitated stable N-terminally V5 peptide-
tagged TDP-43 protein expression in late-stage chick motor
neurons (Fig. 5A). Intracellular localization of the different TDP-
43 variants in chick motor neurons accurately mirrored that
observedforthecorrespondingproteinvariantsinHEKcells(Fig.2)
and Drosophila non-neuronal (Fig. S1) and neuronal cells (Fig. 3).
Unilateral expression of TDP-43
WT in postmitotic motor neurons
for 6 days triggered loss of roughly 30% Isl1/2
+ spinal motor
neurons relative to the untransfected control hemicord (Fig. 5B).
Significant, but comparatively milder motor neuron loss was
observed upon expression of TDP-43
DNLS and TDP-43
A315T. Loss
of motor neurons by TDP-43
WT, TDP-43
A315T and TDP-43
DNLS
was further preceded by transient increase in Caspase-3
+ motor
neuron numbers, mirroring the relative impact of TDP-43 variants
on overall reduction of motor neurons numbers (Fig. 5C). This
suggested that motor neuron loss occurred at least in part via
caspase-dependent apoptotic elimination.
TDP-43-mediated motor neuron loss in chick requires
RNA-binding function
Expression of TDP-43
CTF (lacking the N-terminal portion
including RRM1) or RNA-binding deficient TDP-43
FFLL,i n
Table 1. Expression of TDP-43 variants.
TDP-43 transgenes Gal4-driver lines used for assay
Site-directed
insertions
elav
C155::Gal4
(pan-neural)
actin5C::Gal4
(ubiquitous, strong)
TDP-43
WT vital lethal
TDP-43
DNLS vital lethal
TDP-43
FFLL vital vital
TDP-43
G287S vital lethal
TDP-43
A315T vital lethal
TDP-43
G348C vital lethal
TDP-43
A382T vital lethal
TDP-43
N390D vital lethal
TDP-43
CTF vital vital
Expression of TDP-43 variants using different Gal4-driver lines. Impact of TDP-43
expression on vitality was assayed.
doi:10.1371/journal.pone.0012247.t001
TDP-43 Neuron Loss
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control vector transfection (Fig. 5B). These data therefore
suggested a requirement for RNA-binding activity for effective
TDP-43-mediated neurotoxicity in chick, analogous to the relative
inertness of TDP-43
FFLL and TDP-43
CTF regarding longevity and
motor function in Drosophila (Fig. 4). In addition, these observations
revealed that protein truncation/mislocalization may have com-
paratively little impact on TDP-43-mediated neurotoxicity, since
TDP-43
CTF and TDP-43
FFLL displayed predominantly cytoplas-
mic or nuclear localization, respectively. To further test this, we
designed cytosolically localized plus RNA-binding deficient TDP-
43
FFLL,DNLS to separate relative impacts of truncation/mislocali-
zation from inherent TDP-43 protein function (Fig. S3B). Similar
to TDP-43
FFLL and TDP-43
CTF, TDP-43
FFLL,DNLS did not
measurably trigger motor neuron loss compared to control
transfections (Fig. 5B). However, for both TDP-43
CTF and TDP-
43
FFLL,DNLS we observed a transient mild increase in Casp-3
+
motor neurons at 2 days after transfection (Fig. 5C); which,
Figure 4. Requirement for RNA-binding activity for TDP-43-mediated neural defects in Drosophila. (A) TDP-43 expression reduces
longevity in Drosophila. Flies with pan-neural (elav::Gal4) expression of indicated TDP-43 variants were assayed for longevity. (B) Median survival of
respective survival curves. (C) Cross-comparison of survival curves with regard to statistical significance after Bonferroni correction. (D) Age-
dependent locomotion defects after TDP-43 expression in motor neurons. Flies expressing indicated TDP-43 variants specifically in motor neurons
(D42::Gal4) were assayed for negative geotaxis at 1, 10 and 20 days post eclosion. (E) Detailed summary of statistical analysis (2-Way ANOVA followed
by Bonferroni post-hoc tests) of age-dependent locomotion effects. Genotypes of flies analyzed: elav
C155::Gal4/Y;UAS::TDP-43/+ in longevity analysis
and w/Y;UAS::TDP-43/+;D42::Gal4/+ in case of locomotion assay. elav
C155::Gal4/Y (longevity) and w/Y;;D42::Gal4 (climbing) served as controls. *p,0.05;
**p,0.01; ***p,0.001; ns not significant.
doi:10.1371/journal.pone.0012247.g004
TDP-43 Neuron Loss
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reduction of motor neuron numbers at later stages (Fig. 5B). While
overexpression of mislocalized RNA-binding deficient TDP-43
may therefore to a degree impact neural integrity, this effect
appeared negligible when directly compared to that exerted by
similar levels of TDP-43 variants retaining inherent RNA-binding
function.
Most ALS/FTLD-linked missense mutations that have been
mapped so far localize to the C-terminal GRD of TDP-43 (see
Fig. 1A) (http://www.molgen.ua.ac.be/FTDmutations). We there-
fore tested the impact on exogenous TDP-43-triggered motor
neuron loss upon removing the C-terminal portion of TDP-43. To
achieve this we introduced into chick motor neurons a synthetic
TDP-43 variant—TDP-43
NTF: TDP-43 ‘‘N-terminal fragment’’—
and tested for both, induction of early apoptosis and eventual
effects on motor neuron numbers (Fig. 5B,C). Similar to TDP-
43
WT and the TDP-43
MS, TDP-43
NTF predominantly localized to
the nucleus (Fig. S3C). However, in contrast to TDP-43
WT and
similar to TDP-43
FFLL and TDP-43
CTF, TDP-43
NTF expression
had no significant impacts on maintenance of normal motor
neuron numbers (Fig. 5B), nor on motor neuron apoptosis levels
(Fig. 5C). Thus, motor neuron loss mediated by exogenous TDP-
43 expression requires both, N-terminally localized inherent RNA-
binding function, as well as the integrity of the C-terminal
section—suggesting the intriguing possibility that C-terminal
TDP-43 missense mutations may act through a pathway
determined by inherent TDP-43 RNA-binding function.
Discussion
This study provides the first direct comparison of the respective
activities of ALS/FTLD-associated variants relative to wild type
TDP-43 with regard to their impacts on neural integrity. By
clarifying the relative impacts of TDP-43 alteration and missense
mutation these results provide important ramification for under-
standing the link between TDP-43 function and neuropathology.
First, equalized TDP-43 protein expression levels in Drosophila
revealed a requirement for inherent TDP-43 RNA-binding
activity for eliciting neural defects. Second, elicitation of neural
defects by TDP-43 expression appeared to be independent from
ALS/FTLD-linked mutations, truncation, or mislocalization, all of
which appeared to at least slightly reduce impacts caused by same-
level expression of TDP-43
WT. Third, transposon-mediated
transgenesis in chick revealed TDP-43-mediated loss of spinal
motor neurons. In this model we observed a dependency of TDP-
43-mediated neurotoxicity on RNA-binding activity, but not
mislocalization, truncation, or missense mutations, therefore
accurately mirroring the results obtained by same-level TDP-43
expression in Drosophila. Together, these data are inconsistent with
models based on a simple gain-of-function effect by TDP-43
missense mutation and/or truncation that would render expres-
sion of the protein neurotoxic.
In our Drosophila model, relative impacts of TDP-43 mutation
and modification on TDP-43
WT-mediated neural deficiency
ranged from mild (A315T) to drastic (N390D; FFLL). This further
highlights the importance of stringently controlling relative protein
levels when investigating the activity of different TDP-43 isoforms.
Accordingly, less overt variant-specific differences in toxicity could
consequently be masked, or misrepresented, by varying TDP-43
concentrations—such as achieved by random-insertion transgen-
esis. For instance, low TDP-43
WT expression levels had only mild
impacts on longevity, while high levels of TDP-43
WT resulted in a
marked reduction of life-span (see Fig. S4A). Moreover, while our
parallel random-insertion transgenes detected clear differences
between impacts on overall viability respectively induced by TDP-
43
WT and TDP-43
CTF expression, more subtle differences
between TDP-43
WT and TDP-43
DNLS—obvious in our w-C31
site-specific transgenes—were not resolved. Previous difficulties in
normalizing relative toxicity to relative protein levels could
therefore account for conflicting results separately showing toxic
effects by either wild type, or ALS/FTLD-linked mutant TDP-43
in vivo.
What could be the link between TDP-43 RNA-binding activity
and manifestation of neuropathology in ALS/FTLD? While this
study focused on in vivo consequences of introducing exogenous
proteins, our results are consistent with the notion that
detrimental effects of exogenous TDP-43 expression could result
from interference with its endogenous function/s involving RNA-
binding. This could in turn reflect inherent dosage-sensitivity of
vital processes controlled by endogenous TDP-43/TBPH towards
alterations in TDP-43/TBPH protein levels—and could account
for the similar neural impacts separately obtained by TDP-43
overexpression and knock down in vivo [10,11,12,13,15,16]. In
analogy, the observed reduction, rather than increase in TDP-43
neurotoxic activity by ALS/FTLD-linked mutations (this study) –
possibly reflecting reduction of inherent protein function – could
consequently point to a loss-of-function mechanism by which
depletion of TDP-43 function (e.g. via missense mutation, and/or
truncation/aggregation, followed by cytosolic sequestration)
would eventually lead to neuron loss [6,7,16]. Our observation
that in chick, motor neuron loss mediated by exogenous TDP-43
expression requires the integrity of the TDP-43 C-terminal
section—in addition to its N-terminally localized RNA-binding
function—could further point to the possibility that ALS/FTLD-
linked C-terminal TDP-43 missense mutations may act through a
pathway determined by inherent TDP-43 RNA-binding function.
While future studies will have to further address these
Table 2. Expression of TDP-43:GFP variants.
TDP-43 transgenes Gal4-driver lines used for assay
Random insertions: elav
C155::Gal4 (pan-neural) DaG32::Gal4 (ubiquitous, weak)
TDP-43
WT:GFP (11 lines) 10 vital, 1 lethal (line #14, used for further analysis) 1 vital,10 lethal
TDP-43
DNLS:GFP (16 lines) 15 vital, 1 lethal 1 vital, 15 lethal
TDP-43
CTF:GFP (11 lines) 11 vital, 0 lethal 11 vital, 0 lethal
ey::Gal4 (eye) repo::Gal4 (glia) MHC::Gal4 (muscle) actin5C::Gal4 (ubiquitous)
TDP-43
WT:GFP #14 vital vital vital lethal
Expression of TDP-43:GFP variants using different Gal4-driver lines. Impact of TDP-43 expression on vitality was assayed.
doi:10.1371/journal.pone.0012247.t002
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PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12247Figure 5. RNA-binding activity is required for TDP-43-mediated motor neuron loss in chick. (A) Stable unilateral expression of human
TDP-43 variants in chick (Gallus gallus) spinal cord. [i] Schematic of expression system mediating motor neuron-restricted expression upon unilateral
transfection. [ii] Unilateral expression of human TDP-43
FFLL (red) in embryonic day 9 (E9) chick spinal cord (nuclei labeled with DAPI: blue): transversal
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physiological roles of TDP-43 in vivo, and their potential
contribution to sustaining neural integrity. Our results further
stress the potential pitfalls of entirely relaying on gain-of-function
approaches to model TDP-43 proteinopathy in vivo.T h e
challenge now lies in the development of appropriate in vivo-
models that more accurately mirror TDP-43 proteinopathy
mechanisms occurring in human ALS and FTLD. Together,
our data resolve the relative impacts of TDP-43 mutation/
alteration and implicate inherent TDP-43 RNA-binding function
in mediating neuronal loss in vivo. This study should therefore
provide an essential entry point for eventually determining the
definitive mechanisms and pathways linking TDP-43 to human
neuropathology.
Methods
Ethics Statement
According to the German ‘‘Tierschutzgesetz’’ (BGBl. I S. 1206,
1313), work dealing with Drosophila and in ovo chick experiments
does not require permission. An ethics statement therefore is not
required for the work reported in this manuscript. All animal work
has been conducted according to relevant national and interna-
tional guidelines.
Flies
All fly stocks were maintained and raised on standard cornmeal-
yeast-agar medium. Unless otherwise noted, all fly strains used in
this study are available at the Bloomington Drosophila stock center.
The site-directed and random-inserted UAS:TDP-43 transgenic
lines were generated by germline transmission (BestGene). Strain
PBac{yellow[+]-attP-3B}VK00002 (cytological region 28E7 on
2nd chromosome; strain identifier at BestGene: 9723) was used to
generate the site-directed insertions of different TDP-43 variants.
Cloning and Mutagenesis
Amino acid changes of TDP-43[WT] were introduced by site-
directed mutagenesis using following primers (sequence 59-39):
F147L/F149L.For: TCAAAGGGGTTAGGCTTAGTTCGT-
TTTACGG
F147L/F149L.Rev: CCGTAAAACGAACTAAGCCTAACC-
CCTTTGA
G287S.For: GCTTTGGGAATCAGAGTGGATTTGGTAATA
G287S.Rev: TATTACCAAATCCACTCTGATTCCCAAAGC
A315T.For: GGGATGAACTTTGGTACGTTCAGCATTAAT
A315T.Rev: ATTAATGCTGAACGTACCAAAGTTCATCCC
G348C.For: CAGAACCAGTCATGCCCATCGGGTA
G348C.Rev: TACCCGATGGGCATGACTGGTTCTG
A382T.For: CTAATTCTGGTGCAACAATTGGTTGGGGA
A382T.Rev: TCCCCAACCAATTGTTGCACCAGAATTAG
N390D.For: GATCAGCATCCGATGCAGGGTCG
N390D.Rev: CGACCCTGCATCGGATGCTGATC
pENTR1A-TDP-43 was used as template. in vitro mutagenesis
was performed using QuikChangeH Site-Directed Mutagenesis Kit
(Stratagene) according to manufacturer’s manual.
Flies. For generation of transgenic flies, TDP-43 variants
were amplified using primers introducing 59-BamHI and 39-XbaI
restriction sites, respectively (see below). Subsequent digest with
respective enzymes allowed sub-cloning into pUASattB vector (cut
with BglII and XbaI).
pENTR1A.For: TTCAGTCGACTGGATCCTATAGGGAG
pENTR1A.Rev: GTCTAGACTACATTCCCCAGCCAGAA
Human cell culture. For expression in human cells,
respective TDP43 variants were subcloned in frame (BamHI/
HindIII) into pcDNA3.1(-) (Invitrogen) with an inserted 59-Flag tag
(NotI/EcoRI).
Chick. The Hb9::Cre vector was a gift from S. Pfaff. The
pCAGGS::T2TP vector [28] was a gift from K. Kawakami. The
expression vector consisted of a pCAGGS promoter, followed by
three SV 40 pA signals flanked by two loxP sites, V5-tag TDP-43
expression cassette, IRES (internal ribosome entry site), MmCherry
open reading frame and a terminating SV40 poly-A signal, and was
inserted between the Tol2-sites as a 59SspI/39XhoI fragment. The
Tol2 vector [29] was a gift from A. Urasaki. The TDP-43 variants
were inserted in frame between the V5-tag and the IRES as a
59XbaI/39SmaI fragment after PCR amplification using the
following primers:
TDP-43 XbaI.For: GCTCTAGAATGTCTGAATATATTCG-
GGTAACC
TDP-43 SmaI.Rev: TCCCCCGGGCTACATTCCCCAGC-
CAGAAGACTT
TDP-43
CTF XbaI.For: GCTCTAGACTGCGGGAGTTCT-
TCT
TDP-43
NTF SmaI.Rev: CCCGGGGGACTATTAAGCATC-
TGTCTCATCCATTT
Longevity
For pan-neural expression, 1
st chromosomal P{w[+mW.hs]=
GawB}elav[C155] (elav
C155::Gal4) was used to drive the different
TDP-43 variants. For embryonic-onset longevity analysis,
elav
C155::Gal4 virgins were crossed to males carrying different
TDP-43 variants (w/Y;UAS::TDP-43ICyO). The F1 generation was
raised at 25uC, male flies with driver and respective TDP-43
transgenes (elav
C155::Gal4/Y;UAS::TDP-43I+) were used for analy-
sis. Driver flies (elav
C155::Gal4/Y) served as control. Statistical
analysis was performed using GraphPad Prism.
In case of adult-onset expression, virgins carrying a temperature
sensitive Gal80 in combination with the pan-neural driver
P{w[+mW.hs]=GawB}elav[C155]; P{w[+mC]=tubP-GAL80[ts]}
20 (elav
c155::Gal4;Gal80[ts]) were crossed to w/Y;UAS::TDP-43ICyO
males, respectively. The F1 generation was raised at 18uCt oa b o l i s h
TDP-43 expression and male flies elav
C155::Gal4/Y;UAS::TDP-
43IGal80[ts] were analyzed. In both paradigms, groups of 10-20
maleflies (0-48 hours posthatching) per vialwere shifted to 29uC, and
dead flies were counted daily. Fresh food vials were provided every
second day. At least 60 flies were analyzed per genotype.
Climbing Assay
The 3
rd chromosomal driver w[*];;P{w[+mW.hs]=GawB}D42
(D42::Gal4) was used to drive motor neuron-specific expression of
section at lumbar levels. ‘‘2’’ and ‘‘+’’ respectively indicate control and transfected hemicords. Isl1/2 labels motor neuron nuclei (green). (B) [i]
Examples of thoracic motor columns (Isl1/2
+ motor neurons: green) upon TDP-43 variant expression (red). [ii] Quantification of motor neuron loss
upon TDP-43 variant expression over all obtained sections (in ‘‘-’’ versus ‘‘+’’ hemicord). Differences relative to control (t-student’s test) are indicated.
(C) [i] Activated Caspase-3 (green) detected in E5 motor neurons upon TDP-43
WT expression (indicated by IRES-cherry bi-cistronic reporter: red).
Compared to E5 motor neurons expressing TDP-43
WT, little activation of Caspase-3 was detected upon TDP-43
CTF expression. [ii] Quantification of
Caspase-3 activation in motor neurons of transfected hemicords versus vector control. Significant differences are indicated (t-student’s test - relative
to control). *p,0.05; **p,0.01; ***p,0.001; ns not significant.
doi:10.1371/journal.pone.0012247.g005
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Y;UAS::TDP-43I+;D42::Gal4/+) were collected (0–48 hours post
hatching) and shifted to 29uC. Individual flies were tested 3 times
per time point (1, 10 and 20 days after temperature shift) for
negative geotaxis (ability to climb 8 cm in 10 s). At least a total
number of 60 flies was used per time point and genotype.
Statistical analysis was performed using GraphPad Prism.
Western Blot
Heads of flies were dissected and homogenized in RIPA buffer
(50 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium
deoxycholate, 1x protease inhibitors (Roche), 1% Nonidet P-40).
Lysates were separated on 12% Gel by SDS-PAGE. Proteins were
transferred to nitrocellulose membrane. Membrane was blocked
with 5% (w/v) skimmed milk Tris buffered saline containing 0.1%
Tween 20. For detection of proteins the following primary
antibodies were used: anti-TARDBP (1:1,000, ProteinTech),
anti-Syntaxin (1:2,500, Developmental Studies Hybridoma Bank
(DSHB)). Secondary HRP-coupled antibodies (1:10,000, Amer-
sham) were used for chemiluminiscence detection (Immun-Star
TM,
WesternC
TM Chemiluminescent Kit, BioRad).
Quantitative PCR analysis
Heads of flies with pan-neural expression of different TDP-43
variants were isolated using Trizol (Invitrogen). For qRT–PCR,
1 mg total RNA was reverse transcribed using Transcriptor High
Fidelity cDNA Synthesis kit (Roche) and anchored oligo-dT
primer. 1/10 dilutions were used in triplicates with 0.2 mM primer
and 5 ml LightCycler 480 SYBR Green I Master in a 10 ml
reaction and qPCR executed in a 384-well block on a LightCycler
480 system (Roche). Amplification efficiencies of targets and
references were determined and used for further calculations of
normalized relative (Delta DeltaC(T)) expression levels according
to [30]. One-way ANOVA with Bonferroni correction was used
for statistical analysis (GraphPad Prism). Primers used for qRT-
PCR amplification:
Actin-5C.For: CACACCGTGCCCATCTACGAGG
Actin-5C.Rev: CTTCTGCATACGGTCGGCGATGC
TDP-43.For: ACTGAGGATGAGCTGCGGGAGTTC
TDP-43.Rev: CAAAGAGACTGCGCAATCTGATCATCTG
TBPH.For: GGAAGGGGCCGAATAACCCGAAC
TBPH.Rev: CACACATCATTGGGTGACAGGCACC
Cell culture
HEK293E cells (Invitrogen) were grown in Dulbecco’s modified
Eagle medium (DMEM), supplemented with 10% fetal bovine
serum (PAA) at 37uC under humidified 5% CO2/air. DNA
transfections were performed with FuGene6 (Roche) according to
manufacturer’s instruction.
RNA crosslinking procedures
UV-crosslinking of in vitro transcribed biotinylated RNA to
protein lysate was performed as described recently [16] with slight
modifications. In brief, 1.5 ml of each sense and antisense HPLC-
purified oligonucleotides (100 pmol/ml) containing a stretch of 12
TG or TC repeats 39 of a T7 promotor sequence (TAATAC-
GACTCACTATAGGG) were diluted in 47 ml annealing buffer
(30 mM Hepes (pH 7.4), 100 mM KAc, 2 mM MgAc) and heated
to 95uC for 5 min. After cooling down slowly, 12 ml of annealed
oligos were in vitro transcribed/biotinylated using Biotin RNA
Labeling Mix and T7 RNA Polymerase (both Roche) according to
manufacturer’s instructions. After digest of DNA, 2 ml of this
reaction were incubated with 250 ml RNA binding buffer (20 mM
HEPES (pH 7.5), 5 mM MgCl2, 50 mM KCl, 150 mM NaCl,
0.5 mM EGTA, 0.5 mM dithiothreitol, 10% glycerol) and
1,000 mg HEK293 lysate for 20 min at 30uC. HEK293 lysates
were generated from HEK293 cells transfected with Flag-TDP-43
wild type or F147L/F149L for 48 h and lysed in RNA binding
buffer +1% Triton X-100. After UV irradiation and brief RNase
A digest, Streptavidin-beads (Sigma) were added and precipita-
tions carried out overnight at 4uC. Eluate and input were
separated by 10% SDS-PAGE, blotted onto nitrocellulose and
probed overnight with antibodies against TDP-43 (1:2,000,
ProteinTech), Flag (1:10,000, Sigma, clone M2) and GAPDH
(1:35,000, Biodesign International) as a loading control.
In ovo electroporation
Fertilized chick (Gallus gallus) eggs were obtained from
Horstmann Geflu ¨gelzucht GmbH. Eggs were incubated at
37.5uC and 80% humidity (J. Hemel-Brutgera ¨te GmbH) for
72 hours (,3 days) to obtain embryos at embryonic day 3 (E3).
Microinjections were performed using a micropipette needle made
from pulled glass capillary tubes. The needle was loaded with a
mixture of DNA, Hb9::Cre (1.0 mg/ml) for motor neuron-specific
expression, pCAGGS::T2TP (1.0 mg/ml) and LTEV containing the
TDP-43 variant (concentration of 1.0 mg/ml). Up to 5 ml of egg
white was removed using a syringe. Afterwards the egg was
windowed in the middle. Egg yolk and the embryo stayed
unharmed during this procedure. The DNA-mixture got injected
into the neural tube (lumbar region) of the embryo. The injection
site was electroporated using an ECM 830 electroporation system
(BTX Harvard Apparatus, Holliston, USA). The electrodes were
placed in parallel so that the developing spinal cord was situated
between the electrodes. Electroporation with the electrodes placed
in this way transported DNA located in the spinal cord towards the
positive electrode, resulting in approximately half of the spinal
cord being transfected. The electroporation settings were 5 pulses
of 25 mV for 50 ms in the LV 99 ms/500 V modus. After
electroporation, the window on the operated egg was sealed with
clear sellotape, and the egg was returned to the incubator.
Chick embryo and tissue processing
Chick embryos were harvested 2 and 6 days after electropora-
tion, and placed in cold 1x PBS. Spinal cords were dissected at
embryonic day 9 (E9), while E5 spinal cords were left intact in the
embryo to minimize damage. Tissues were fixed by immersion in
4% PFA (in 1x PBS) (1.5–2.5 h for E5, 4–6 h for E9) and then
washed in 1x PBS overnight. Afterwards the tissue was incubated
in 30% sucrose (in 1x PBS) overnight. All previous steps were
taken out at 4uC. Ready fixed tissue was imbedded into OCT
(Jung, Nussloch). Transversal cryosections of the spinal cord were
cut in a CM1900 cryostat (Leica, Bensheim) at 220uC and placed
on a super frost glass slide.
Immunohistochemistry
Chick immunofluorescent staining was performed on 30 mm
slices of prefixed E5 and E9 chick embryo spinal cord. For primary
antibody detection the slides were incubated in a humidified box
overnight at 4uC, utilizing 1% BSA (fraction V) in 1x PBS with
0.5% Triton X-100 to enhance tissue penetration. Slides were
washed with 1x PBS before the secondary staining, which was
carried out with the same detergent for 30 min–1 h at RT. Slides
were washed again with 1x PBS and stained with DAPI (Roth,
1:10
6 w/v) at RT for 10–20 min. After DAPI staining, the slides
were washed with 1x PBS, mounted with 50% glycerol and cover
slipped. Primary antibodies: rabbit anti-Isl1/2 (K5, 1:2,500, gift
from Samuel L. Pfaff), mouse anti-Isl1 (DSHB, 1:200), mouse anti-
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anti-mouse (Invitrogen, 1:1,000), Alexa 488 mouse anti-rabbit
(Invitrogen, 1:1,000), Alexa 647 mouse anti-rabbit (Invitrogen,
1:1,000), Alexa 488 rabbit anti-mouse (Invitrogen, 1:1,000). All
images of mounted slices were collected using a Leica TCS/MP
confocal/two-photon microscope. All images were acquired from
30 mm sections of the chick embryo spinal cord at the
developmental stages of E5 and E9. Images of the E9 sections
were acquired by using the 20x objective with 2x zoom. Images of
the E5 sections were acquired with the 40x objective and 2x zoom.
For both developmental stages (E5, E9) all images were a total of a
50–80 mm stack of 10 z-sections subsequently collapsed to a 2D
rendering using ImageJ. Motor neuron survival was measured by
counting Isl1/2 positive cells in the ventral horn, electroporated vs.
non-electroporated side. The counting was performed using the
Olympus Cell‘M imaging station.
Drosophila brains and eye discs were dissected in 1x PBS +0.1%
Triton X-100 (PBST) and fixed in PBS +4% PFA for 20 min at
RT. Primary antibody detection was performed at 4uC in PBST
supplemented with 5% BSA (fraction V) over night. Tissue was
washed in PBST before secondary antibodies were applied (2 h at
RT). Specimen was mounted in VectashieldH mounting medium
(Vector Laboratories) +/2 DAPI. Primary antibodies: mouse anti-
TDP-43 (1:1,000, ProteinTech). Secondary antibodies: Alexa 488
goat-anti mouse (Invitrogen, 1:500). Alexa Fluor 568 phalloidin
(Invitrogen) was used to stain F-actin (1 unit/staining) and for
confocal analysis, DNA was visualized using SytoxH Orange
(Molecular Probes, 5 mM). Epifluorescent pictures were acquired
at Olympus BX51 microscope (10x or 40x objectives) using Cell‘F
software. Confocal sectioning was performed at Leica TCS/MP
confocal/two-photon microscope using 20x objective with 2x
zoom.
HEK293E cells were plated onto glass coverslips coated with
PDL (Sigma) and collagen (Cohesion), fixed with 4% (w/v)
paraformaldehyde and permeabilized with 1% Triton X-100 48h
after transfection with Flag-tagged TDP-43 variants. Cells were
incubated with primary antibodies (anti-TDP-43; 1:2,000 and
anti-Flag, 1:500; Sigma, clone M2) followed incubation with
secondary antibodies anti-mouse IgG Alexa Fluor-and anti-rabbit
Alexa Fluor-568 (Molecular Probes) diluted 1:2000. Nuclei were
stained with Hoechst 33342 (Molecular Probes) diluted 1:5000.
Coverslips were mounted onto microscope slides using fluorescent
mounting medium (Dako). Confocal fluorescent images were taken
with an AxioImager microscope equipped with an ApoTome
Imaging System (Zeiss).
Supporting Information
Figure S1 Localization of TDP-43 in non-neuronal cells of
Drosophila. Salivary glands of Drosophila larvae were used to address
subcellular localization of TDP-43 variants due to their large cell
and nucleus size. Epifluorescence pictures of gland cells stained for
TDP-43 (green) and f-Actin (red) using phalloidine (upper panel).
Nuclear localization of TDP-43
WT and TDP-43
MS is visualized by
colocalization with DAPI (blue) stained nuclei (middle panel) and
illustrated by plotted fluorescence distribution (lower panel). Line
indicates distance used for fluorescence measure. Note that of the
assayed TDP-43 variants, only TDP-43
DNLS displayed robust
cytoplasmic localization (B).
Found at: doi:10.1371/journal.pone.0012247.s001 (4.10 MB TIF)
Figure S2 Subcellular localization of TDP-43:GFP variants in
Drosophila. We were not able to efficiently detect TDP-43
CTF with
our TDP-43 antibody directed to the N-terminal portion of the
protein. To circumvent this problem, in addition to w-C31 site-
specific recombination, we also utilized random-insertion trans-
genesis in Drosophila to generate C-terminal GFP-tagged TDP-43
variants for TDP-43
WT (A), TDP-43
DNLS (B) and TDP-43
CTF (C),
(TDP-43
WT:GFP, TDP-43
DNLS:GFP and TDP-43
CTF:GFP, re-
spectively). This allowed us to visualize TDP-43:GFP (green)
directly. First we tested the different variants in non-neuronal cells
of the salivary glands of L3 larvae (left). Epifluorescence analysis
revealed that GFP-tagged TDP-43
WT and TDP-43
DNLS localized
alike the untagged variants. (A) TDP-43
WT:GFP showed nuclear
localization, evident by colocalization with DAPI stained DNA
(blue). (B) TDP-43
DNLS:GFP was found to evenly distributed in the
cytoplasm and almost not detected in the nucleus. Thus, the C-
terminal GFP-tag did not alter localization, as it was also observed
in HEK cells (not shown). (C) TDP-43
CTF:GFP showed a strong
cytoplasmic as well as a nuclear localization, similar to the
situation observed in chick (compare to Fig S3A). In Drosophila
larvae, photoreceptors and their nuclei are located in the eye
imaginal disc, from where photoreceptors project via the optic
nerve into the optic lobes of the brain. We used the visual system
to analyze the distribution of the TDP-43:GFP variants in these
neuronal cells (right). Expression of all three constructs in
photoreceptors (GMR::Gal4) resulted in a robust accumulation of
GFP signal in targeted cells of the eye disc (not shown). As
expected, larvae expressing TDP-43
WT:GFP did not display any
GFP signal in photoreceptor projections (A), as localization was
restricted to the nuclei of the eye disc (see also Fig. 3A). In contrast,
we could detect robust staining in photoreceptor projections in
TDP-43
DNLS:GFP and TDP-43
CTF:GFP (B, C). This indicates
that cytoplasmic DNLS and CTF variants of TDP-43:GFP were
distributed throughout neurons and were not restricted to the
soma. Scale bar indicates 100 mm.
Found at: doi:10.1371/journal.pone.0012247.s002 (2.36 MB TIF)
Figure S3 Subcellular localization of additional TDP-43 vari-
ants in Gallus. Subcellular localization of TDP-43 variants (red) in
E9 chick motor neurons (large DAPI+ nuclei: white). In analogy to
cytosolic and nuclear localization observed in flies, TDP-43
CTF (A)
in chick localized alike and displayed frequent cytosolic foci
(arrowheads). To test if the lack of RNA-binding also abolishes
toxicity of cytoplasmic TDP-43, we combined RNA-binding
deficient FFLL with the mutated NLS and generated TDP-
43
DNLS,FFLL. As observed for TDP-43
DNLS (compare Fig. 3B),
TDP- 43
DNLS,FFLL localized predominantly to the cytoplasm (B).
Thus, interference with RNA-binding of TDP-43 did not alter
localization. Interestingly, TDP-43
DNLS,FFLL was found to induce
significantly lower Caspase-3 activation as compared to TDP-
43
DNLS (see Fig. 5Cii). This indicated that RNA-binding of TDP-
43 is required to mediate neurotoxicity, independent of nuclear or
cytoplasmic localization. TDP-43
CTF was found to induce
comparatively mild, if any toxicity in our in vivo systems (see
Fig. 4 and Fig. 5B, C). As TDP-43
CTF lacks the first RRM, found
to be crucial to mediate TDP-43 induced toxicity, we reasoned
that the N-terminal fragment TDP-43
NTF (amino acids 1-263,
containing RRM1/2) might display marked effects after expres-
sion in chick motor neurons. Although we achieved high
expression levels and nuclear localization of TDP-43
NTF in motor
neurons (C), we could not detect elevated motor neuron loss (see
Fig. 5B) or enhanced Caspase activation compared to vector
control (see Fig. 5C). Scale bar indicates 50 mm.
Found at: doi:10.1371/journal.pone.0012247.s003 (4.86 MB
TIF)
Figure S4 Reduction in longevity is dose-dependent and
inducible in an adult-onset expression system. (A) Two TDP-
43
WT:GFP lines displaying different expression levels in Western
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expression. The line with stronger expression, TDP-
43
WT:GFP#16 displayed an earlier lethality as compared to the
weaker expressing line TDP-43
WT:GFP#10. This indicates that
toxicity induced by pan-neural expression of TDP-43
WT is dose-
dependent. According to the GFP-Tag, we were able to compare
protein abundance of different TDP-43
CTF:GFP transgenes.
Compared to TDP-43
WT:GFP#10, TDP-43
CTF:GFP#14 showed
higher levels of protein expression. In spite of these high protein
levels, longevity was not as strongly reduced as observed for TDP-
43
WT:GFP expressing flies. (B) Verification of pan-neural adult-
onset expression in Western blot analysis. Flies were raised at
restrictive condition (rc, 18uC), and TDP-43 expression was
induced 2 days post eclosion by a temperature shift (29uC). Head
lysates taken at indicated time points were analyzed for TDP-43
expression. No TDP-43
WT:GFP expression could be detected
under rc, but was induced at 29uC. Increasing TDP-43 protein
levels were detected over time. (C) Flies with adult-onset pan-
neural expression of indicated TDP-43 variants were assayed for
longevity. Note that line TDP-43
WT:GFP#14, lethal in embry-
onic-onset expression paradigm, survived to adulthood in the
adult-onset expression, but displayed a very short longevity after
induction of expression. For untagged and site-directed TDP-43
transgenes, the order of toxicity is comparable to the embryonic-
onset paradigm (see Fig. 4).
Found at: doi:10.1371/journal.pone.0012247.s004 (0.55 MB TIF)
Video S1 Abnormal locomotion and wing posture in aged TDP-
43
WT expressing flies. Example of a fly with pan-neural expression
of TDP-43
WT. Note the lateral ‘‘hanging wing’’ phenotype.
Dependent on expression strength and time, TDP-43
WT flies lost
their ability to fly, had reduced escape behavior (even if pushed
with a brush) and were not able to reach an upright position after
being placed dorsal side down in a reasonable time.
Found at: doi:10.1371/journal.pone.0012247.s005 (1.35 MB
MOV)
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